There is a habit in a lot of Ayurvedic writing on joint disease of reaching for one word — Amavata — and treating it as if Charaka handed us a single, tidy diagnosis for every aching joint. In more than twenty years of clinical practice, I have found that this is not what the Charaka Samhita says, and reading it that way costs the patient a correct classification.
Charaka does use the word ama in the context of vata. But he never carves out Amavata as a separate, self-contained disease the way later writers did. What Charaka actually gives us is more useful than a label: he gives us pathological processes. When you read the Samhita properly, the chapters are not disease names — they are pathological clusters, each one carrying a full account of how the disease comes to be. For the joints, that resolves into two distinct pathways. Confusing them is the single most common error I see in how classical Ayurveda gets applied to arthritis.
Two roads to a painful joint
Broadly, joint disease in the Charaka framework travels one of two roads.
The first is degeneration — the wear-driven, age-driven, structural breakdown of a joint. This sits under Vatavyadhi, and when it localises to a joint we speak of Sandhigata Vata. This is the territory of osteoarthritis.
The second is immune-driven, inflammatory joint disease — rheumatoid arthritis, ankylosing spondylitis, Sjögren's, and the connective-tissue conditions. This sits under Vatarakta. The clinical thread running through this cluster, in modern terms, is vasculitis — inflammation with the blood as a full participant, not a bystander.
These are not two names for one thing. They are two different pathological sequences, and Charaka describes each one precisely enough that you can tell them apart from the mechanism up.
Vatarakta: the blood-obstructed pathway
For the inflammatory, autoimmune cluster, Charaka states the pathology with striking economy:
वायुर्विवृद्धो वृद्धेन रक्तेनावारितः पथि | कृत्स्नं सन्दूषयेद्रक्तं तज्ज्ञेयं वातशोणितम् | खुडं वातबलासाख्यमाढ्यवातं च नामभिः ||
Aggravated Vata, obstructed in its path by aggravated Rakta, goes on to corrupt the entire blood — and that is what is known as Vatashonita (Vatarakta), also called khuda, vatabalasa, and adhyavata.
Three points matter here for the clinician.
First, the mechanism is one of obstruction — avarana. Vata is not moving into an empty space; it is blocked by vitiated Rakta and, in that collision, the whole of the blood is corrupted. That word kritsnam — the entire blood — is why this reads, in modern pathology, as a systemic vascular process rather than a purely local joint problem. A disease that corrupts the whole blood does not stay in one knee. It travels, it takes the eyes, the skin, the vessels — which is exactly the extra-articular behaviour of the autoimmune arthritides.
Second, the three names Charaka lists — khuda, vatabalasa, adhyavata — are synonyms for this one condition, not clinically distinct sub-diseases. I mention them because a patient or a scholar will encounter them, but I do not build separate treatment logic around them. They describe the same pathology.
Third, this is the classical anchor for why we treat the inflammatory joint diseases as a blood problem, not a bone problem. The distinction changes management entirely.
Vatavyadhi and Sandhigata Vata: the empty-channel pathway
The degenerative road is described by a different mechanism altogether:
देहे स्रोतांसि रिक्तानि पूरयित्वाऽनिलो बली | करोति विविधान् व्याधीन् सर्वाङ्गैकाङ्गसंश्रितान् |
The powerful Vata, having filled the emptied channels of the body, produces various diseases — some spread across the whole body, some confined to a single part.
The operative word is riktani — emptied. And this is where the classical text and modern joint pathology line up almost exactly. In osteoarthritis, the early event is a porosity — the bone begins to lose its density and integrity. Into that porous, emptied space, the blood capillaries begin to migrate, and what follows is sclerotic change and progressive damage to the cartilage. The channel empties first; then Vata fills what has been vacated. Depletion comes before the damage.
This is not a loose analogy. Chakrapani, commenting on this very passage, is explicit about what riktani means:
रिक्तानीति तुच्छानि, स्नेहादिगुणशून्यानीत्यर्थः
Rikta here means tuccha — empty in the sense of being void of unctuousness and its qualities (snehadi-guna-shunya). And in the same commentary he glosses the process as dhatunam karshana — the drawing-down and wasting of the tissues. In other words, the emptiness is dhatukshaya: tissue depletion. Vata does not obstruct here; it enters where the tissue has already been worn thin.
That single commentarial gloss is the hinge that separates the two pathologies cleanly. Vatarakta is avarana — obstruction. Sandhigata Vata is kshaya — depletion. One is the blood colliding; the other is the channel emptying. A patient with rheumatoid arthritis and a patient with knee osteoarthritis are on two different roads, and Charaka told us so.
I want to give Sandhigata Vata its full weight here, not treat it as a footnote to degeneration. The localisation of Vata to the joint, on a foundation of dhatukshaya, is its own clinical entity — and reading it as depletion-first is what stops us from treating a worn joint as though it were an inflamed one.
Why the classification is the clinical work
Here is the part I most want a referring physician to take away, because it is usually misunderstood.
Classifying a joint disease as Vatarakta versus Vatavyadhi is not an alternative to the MRI, the seropositivity, or the Ficat and Kellgren–Lawrence staging. It comes before them, and it is a different kind of act.
Every one of those diagnostic tests carries the same instruction on the report itself: correlate clinically. That phrase is not a formality. The imaging and the serology confirm a clinical diagnosis; they do not establish the pathology on their own. If a report established the disease by itself, there would be no need for the words correlate clinically printed on it. The clinical diagnosis — the reading of the process, whether in classical or conventional terms — is what does the establishing. The test is the confirmation.
So when I place a patient's presentation against the Charaka framework, I am doing diagnostic work that the imaging then confirms or refines. The two are not in competition. The staging tells me how far along the structural damage has gone; the classical read tells me which process I am dealing with and therefore how to manage it. I use both. I would never ask a patient to skip the workup, stop a prescribed medication, or delay a surgical opinion on the strength of a classical classification — Ayurvedic management here complements conventional care, it does not replace it.
But the classification is not decoration. Whether a joint is on the avarana road of Vatarakta or the kshaya road of Sandhigata Vata determines everything that follows in treatment. That is why it is worth getting right, and that is why reducing all of it to a single borrowed word does the patient a disservice.
This article is for educational purposes and reflects clinical experience in Ayurvedic practice. It is not a substitute for individualized medical evaluation. Particularly for inflammatory and autoimmune joint disease, where delayed conventional treatment can have serious consequences. Please consult a qualified physician for assessment specific to your case.